---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-296812"
form_type: "8-K"
ticker: null
cik: "0001580063"
company_name: "BIORA THERAPEUTICS, INC."
filed_at: "2023-12-15T23:59:59+00:00"
generated_at: "2026-06-07T11:54:35.191671+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Biora Therapeutics receives Nasdaq notice of non-compliance with MVLS minimum $50M requirement

## Summary
- Received Nasdaq notification on Dec 11, 2023 that MVLS was below $50M for 30 consecutive business days.
- Company has 180 calendar days, until June 10, 2024, to regain compliance.
- To regain compliance, MVLS must equal or exceed $50M for at least ten consecutive business days.
- If not compliant by deadline, Nasdaq will initiate delisting; company may appeal or transfer to Nasdaq Capital Market.
- No immediate effect on listing or trading of common stock on Nasdaq Global Market.

## SEC filing metadata
- accession: 0001193125-23-296812
- form_type: 8-K
- cik: 0001580063
- company_name: BIORA THERAPEUTICS, INC.
- filed_at: 2023-12-15T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1580063/000119312523296812/0001193125-23-296812-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1580063/000119312523296812/d77822d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-296812
- JSON: https://secwatch.observer/filing/0001193125-23-296812.json
- Plain text: https://secwatch.observer/filing/0001193125-23-296812.txt

## Key facts
- Listing & Compliance Notices
  BIORA THERAPEUTICS, INC. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A), 5810(c)(3)(C)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: market value
  - Rules: 5450(b)(2)(A), 5810(c)(3)(C)
  source text: June 10, 2024 (the “Compliance Date”), to regain compliance with the MVLS Rule. To regain compliance with the MVLS Rule, the Company’s MVLS must equal or exceed $50 million for a minimum of ten consecutive business days at any time prior to the Compliance Date. If the Company regains compliance with the MVLS Rule, Nasdaq will provide the Company with written confirmation and will close the matter. In the event that the Company does not regain compliance with the MVLS Rule by the Compliance Date, it will receive written notification that its securities are subject to delisting. At that time, th
  evidence_url: https://www.sec.gov/Archives/edgar/data/1580063/000119312523296812/0001193125-23-296812-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.